CURRENT NEWS & EVENTS

ITP RevBio Receives FDA approval for a first in-human Clinical Trial!
ITP PI, Dr. Isabelle Lombaert wins the 2023 University of Michigan Medical School’s Frankel Innovation Initiative Award!
RevBio Awarded a $3.4 Million NIH Grant
Congratulations to our ITP teams presenting at Forsyth dentech 2023!
SAVE THE DATE! 2024 MPWRM Resource Center Stakeholder’s Summit – April 8-9, 2024
SAVE THE DATE! 2023 DOCTRC Retreat – December 4-6, 2023 in Los Angeles, CA
MPWRM Resource Center and DOCTRC were highlighted in the keynote talk at NIDCR’s 75th anniversary event, NIDCR at 75: Celebrating the Past, Charting the Future
RevBio Receives ISO 13485 Certification for its Quality Management System!
GreenMark Biomedical Launches CrystLCare™ Biorestorative, Fluoride-Free!
GreenMark Biomedical’s LumiCare Carries Detection Rinse makes the cover of Dental Products Report!

OUR MISSION

Our mission is to strategically partner with scientists, engineers and clinicians to translate dental, oral and craniofacial tissue engineering and regenerative medicine technologies to the clinical marketplace. We assist by building a customized approach for success utilizing an innovative toolkit, access to an exclusive mentorship and an expansive community of translational resources.

NEW TRAINING RESOURCES

To view our latest training resources, click the link below.

LATEST HIGHLIGHTS

MRS TV features Resource Center

NEWS & EVENTS

Read about the latest news and developments.

INTERDISCIPLINARY TRANSLATIONAL PROJECTS PROGRAM

The MPWRM Resource Center’s Interdisciplinary Translational Project (ITP) Program provides funding to support the clinical translation of promising technologies that address clear unmet needs with market potential in the dental, oral and craniofacial (DOC) space. The MPWRM Resource Center brings together a multi-disciplinary team of clinicans, engineers, scientists, and technology commercialization and regulatory experts to support the ITPs and to guide these technologies towards FDA submissions to achieve high impact clinical outcomes.